日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantifying Disease Activity Despite Treatment with Tumor Necrosis Factor Inhibitors Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World Results from the PPD CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

量化接受肿瘤坏死因子抑制剂治疗的银屑病关节炎和中轴型脊柱关节炎患者的疾病活动度:来自 PPD CorEvitas 银屑病关节炎/脊柱关节炎注册研究的真实世界结果

Mease, Philip; Ye, Xiaolan; Saffore, Christopher D; Parikh, Bhumik; Ciecinski, Sandra; Blachley, Taylor; Eliot, Melissa; Middaugh, Nicole; Ogdie, Alexis

A Real-World Comparison of Clinical Effectiveness of Upadacitinib, Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis After Switching from an Initial Tumor Necrosis Factor Inhibitor Treatment

一项真实世界研究比较了乌帕替尼、肿瘤坏死因子抑制剂或白细胞介素-17抑制剂在轴性脊柱关节炎患者中,从初始肿瘤坏死因子抑制剂治疗转换后的临床疗效。

Baraliakos, Xenofon; Saffore, Christopher D; Ye, Xiaolan; Urbanik, Jamie; Stigler, Jayne; Edwards, Molly; Truman, Isabel; Barlow, Sophie; Deodhar, Atul

Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe

利沙珠单抗治疗生物制剂初治银屑病关节炎患者的真实世界疗效和满意度:美国和欧洲人群调查

Walsh, Jessica A; Saffore, Christopher D; Ye, Xiaolan; Patel, Manish; Biljan, Ana; Vora, Jamie; Truman, Isabel; Edwards, Molly; Milligan, Gary; Ostor, Andrew

Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials

乌帕替尼治疗免疫介导炎症性疾病的安全性:随机对照试验间接和直接治疗比较的系统文献综述

Mysler, Eduardo; Burmester, Gerd R; Saffore, Christopher D; Liu, John; Wegrzyn, Lani; Yang, Chelsey; Betts, Keith A; Wang, Yan; Irvine, Alan D; Panaccione, Remo

Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

更正:先进疗法治疗活动性强直性脊柱炎的临床和经济效益

Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew

Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria

根据ASDAS低疾病活动度标准评估的先进疗法在治疗放射学轴性脊柱关节炎或强直性脊柱炎中的疗效比较

Baraliakos, Xenofon; Saffore, Christopher D; Collins, Eric B; Parikh, Bhumik; Ye, Xiaolan; Walsh, Jessica A

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

银屑病关节炎和强直性脊柱炎疾病控制的临床和经济效益:来自OM1注册研究的回顾性分析

Bergman, Martin J; Zueger, Patrick; Patel, Jayeshkumar; Saffore, Christopher D; Topuria, Ia; Cavanaugh, Cristi; Fang, Siran; Clewell, Jerry; Ogdie, Alexis

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

乌帕替尼对生物制剂难治性强直性脊柱炎患者的疾病活动度、疼痛、疲劳、功能、健康相关生活质量和工作效率的影响

Navarro-Compán, Victoria; Baraliakos, Xenofon; Magrey, Marina; Östör, Andrew; Saffore, Christopher D; Mittal, Manish; Song, In-Ho; Ganz, Fabiana; Stigler, Jayne; Deodhar, Atul

Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2

乌帕替尼对活动性非放射性中轴型脊柱关节炎患者生活质量和工作效率的影响:一项随机3期临床试验SELECT-AXIS 2的结果

Kiltz, Uta; Kishimoto, Mitsumasa; Walsh, Jessica A; Sampaio-Barros, Percival; Mittal, Manish; Saffore, Christopher D; Wung, Peter; Ganz, Fabiana; Biljan, Ana; Poddubnyy, Denis

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

先进疗法治疗活动性强直性脊柱炎的临床和经济效益

Walsh, Jessica A; Saffore, Christopher D; Collins, Eric B; Ostor, Andrew